The UK’s National Health Service has launched a vaccination campaign to provide free meningitis B protection to young people in England. The initiative targets around one million eligible individuals, including 17 and 18-year-olds in sixth form, students under 25 entering residential colleges or universities for the first time, and those born between specific date ranges.
The vaccine campaign was initiated following an outbreak in Kent that occurred earlier this year. That outbreak was characterized as unprecedented and explosive, with 29 confirmed or suspected cases and 2 deaths documented within weeks. Nearly 90,000 doses have already been administered, with an additional 135,000 scheduled for coming weeks.
Eligible individuals can access the vaccine through high street pharmacies across England or via the NHS National Booking Service for those already registered with a general practitioner. The vaccine requires two doses administered at least 28 days apart for complete protection. Walk-in services are available at participating pharmacies for those born on or after 21 July 2001 who are beginning higher education or residential further education for the first time. International students and those from other UK nations studying in England are also eligible.
The meningitis B vaccine protects against a specific dangerous strain of the disease and does not contain live bacteria. Common side effects include localized swelling or redness at the injection site, with some individuals experiencing mild fever, nausea, headache or muscle aches that typically resolve within one to two days. Serious side effects are rare. Health officials note that meningitis B can cause serious complications including inflammation of the brain’s lining and blood poisoning, potentially leading to life-altering disabilities or fatality.
Students in their first year of university face approximately seven times higher risk of meningitis infection compared to non-university-attending peers of similar age, according to NHS England. This elevated risk stems from increased social mixing and close living quarters. The vaccine was incorporated into routine childhood immunizations for babies born on or after 1 July 2015, meaning teenagers and young adults over age 11 have not previously received it. UK vaccine experts have suggested government should consider routine vaccination for all teenagers around age 15, though final decisions rest with ministers in each nation.
Article Attribution | Read More at Article Source
Article summary produced by Claude AI